Abstract:1 The use of pharmacokinetics in toxicology, clinical pharmacology and in the individualization of dosage has been critically examined. 2 In toxicity studies, doses are given to animals with the aim of achieving substantially higher plasma levels than the therapeutic level in man. However, small animals have faster metabolic rates, shorter life spans and drug clearance is many fold faster than in man, and this difference may not be compensated for by simply mg per kg dosing. Since toxicity still occurs at these lower levels, it begs the question whether small animals require such high doses to produce toxic effects. 3 A literature survey revealed that only 5 to 31% of the papers studied attempt to relate activity with plasma levels. Examples are given of how such relationships can be used, as with p-fenfluramine, where by investigating individual responses using drug plasma levels as a probe, a greater understanding of eating disorders may be obtained. Also, with tertatolol its prolonged pharmacological activity (> 24 h) can be explained mathematically despite a plasma half-life of only 3 h. 4 The advantages and disadvantages of population kinetics are discussed in relation to its use in individualizing dosage, particularly in disease, its appreciation by pharmaceutical companies and regulatory authorities and the information which has been obtained so far. 5 It is of interest that one of the youngest of drug development disciplines, pharmacokinetics, is now one of the most important.

On separation of time scales in pharmacokinetics

On applications of conservation laws in pharmacokinetics

On modelling of bioavailability of drugs in terms of conservation laws

Upholding or Breaking the Law of Superposition in Pharmacokinetics

On inconsistencies in passive pharmacokinetics

Fractional calculus in pharmacokinetics

Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models

Clearance concepts in pharmacokinetics

Pharmacokinetic model for extravascular administration based on uncertain differential equation

New Approaches to the Use of Pharmacokinetics in Toxicology and Drug Development

Modeling and administration scheduling of fractional-order pharmacokinetic systems

Revising Berg-Purcell for finite receptor kinetics

The kinetics of three coupled irreversible elementary reactions: two parallel mixed second order reactions followed by a first order reaction

Physiological basis of multicompartmental models of drug distribution

Checking distributional assumptions for pharmacokinetic summary statistics based on simulations with compartmental models

On the Way to More Convenient Description of Drug-Plasma Protein Binding

Quasiequilibrium approximation of fast reaction kinetics in stochastic biochemical systems.

A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion

Methods for Non-Compartmental Pharmacokinetic Analysis With Observations Below the Limit of Quantification